N-acetylcysteine-induced vasodilation involves voltage-gated potassium channels in rat aorta

Life Sciences

Volumn 84, Issue 21-22, 2009, Pages 732-737

  Han, Wei Qing ^a   Zhu, Ding Liang ^b   Wu, Ling Yun ^b   Chen, Qi Zhi ^b   Guo, Shu Jie ^b   Gao, Ping Jin ^a,b  

^a Shanghai Jiao Tong University Affiliated Sixth People s Hospital   (China)

^b SHANGHAI SECOND MEDICAL UNIVERSITY   (China)

Author keywords

Endothelium; N acetylcysteine; Reactive oxygen species; Vasodilation; Voltage gated K+ channels

Indexed keywords

4 AMINOPYRIDINE; ACETYLCYSTEINE; ARGININE; CALCIUM CHANNEL; CYCLIC GMP; FLUORESCENT DYE; GUANYLATE CYCLASE INHIBITOR; NITRIC OXIDE; PHENYLEPHRINE; REACTIVE OXYGEN METABOLITE; VOLTAGE GATED POTASSIUM CHANNEL;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; AORTA; ARTERY CONSTRICTION; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; EXTRACELLULAR CALCIUM; IN VITRO STUDY; LASER MICROSCOPY; MALE; NONHUMAN; RAT; SMOOTH MUSCLE FIBER; VASCULAR SMOOTH MUSCLE; VASODILATATION;

ACETYLCYSTEINE; ANIMALS; CALCIUM; CYCLIC AMP; CYCLIC AMP-DEPENDENT PROTEIN KINASES; GUANYLATE CYCLASE; MUSCLE CONTRACTION; MUSCLE, SMOOTH, VASCULAR; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE III; OMEGA-N-METHYLARGININE; OXADIAZOLES; PHENYLEPHRINE; POTASSIUM CHANNEL BLOCKERS; POTASSIUM CHANNELS, VOLTAGE-GATED; PROTEIN KINASE C; QUINOXALINES; RATS; RATS, SPRAGUE-DAWLEY; REACTIVE OXYGEN SPECIES; VASOCONSTRICTOR AGENTS; VASODILATION;

RATTUS;

EID: 67349115959     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lfs.2009.02.023     Document Type: Article

References (24)

1. Armstead W.M. Role of ATP-sensitive K+ channels in cGMP-mediated pial artery vasodilation. American Journal of Physiology 270 2 Pt 2 (1996) H423-426
2. Barrios V., Calderon A., Navarro-Cid J., Lahera V., and Ruilope L.M. N-acetylcysteine potentiates the antihypertensive effect of ACE inhibitors in hypertensive patients. Blood Pressure 11 4 (2002) 235-239
3. Cai T., Yao T., Li Y., Chen Y., Du K., Chen J., and Luo W. Proteasome inhibition is associated with manganese-induced oxidative injury in PC12 cells. Brain Research 1185 (2007) 359-365
4. Cox R.H. Molecular determinants of voltage-gated potassium currents in vascular smooth muscle. Cell Biochemistry and Biophysics 42 2 (2005) 167-195
5. Ghosh M., Wang H.D., and McNeill J.R. Tiron exerts effects unrelated to its role as a scavenger of superoxide anion: effects on calcium binding and vascular responses. Canadian Journal of Physiology and Pharmacology 80 8 (2002) 755-760
6. Girouard H., Chulak C., Wu L., Lejossec M., and de Champlain J. N-acetylcysteine improves nitric oxide and alpha-adrenergic pathways in mesenteric beds of spontaneously hypertensive rats. American Journal of Hypertension 16 7 (2003) 577-584
7. Kaczorowski G.J., and Garcia M.L. Pharmacology of voltage-gated and calcium-activated potassium channels. Current Opinion in Chemical Biology 3 4 (1999) 448-458
8. Kim D., Aizawa T., Wei H., Pi X., Rybalkin S.D., Berk B.C., and Yan C. Angiotensin II increases phosphodiesterase 5A expression in vascular smooth muscle cells: a mechanism by which angiotensin II antagonizes cGMP signaling. Journal of Molecular and Cellular Cardiology 38 1 (2005) 175-184
9. Krug S., Zhang Y., Mori T.A., Croft K.D., Vickers J.J., Langton L.K., and Whitworth J.A. N-acetylcysteine prevents but does not reverse dexamethasone-induced hypertension. Clinical and Experimental Pharmacology and Physiology 35 8 (2008) 979-981
10. Lachmanova V., Hnilickova O., Povysilova V., Hampl V., and Herget J. N-acetylcysteine inhibits hypoxic pulmonary hypertension most effectively in the initial phase of chronic hypoxia. Life Sciences 77 2 (2005) 175-182
11. Lee M.Y., and Griendling K.K. Redox signaling, vascular function, and hypertension. Antioxidants & Redox Signalling 10 6 (2008) 1045-1059
12. Li S., Gosling M., Poll C.T., Westwick J., and Cox B. Therapeutic scope of modulation of non-voltage-gated cation channels. Drug Discovery Today 10 2 (2005) 129-137
13. Martina V., Masha A., Gigliardi V.R., Brocato L., Manzato E., Berchio A., Massarenti P., Settanni F., Della Casa L., Bergamini S., and Iannone A. Long-term N-acetylcysteine and l-arginine administration reduces endothelial activation and systolic blood pressure in hypertensive patients with type 2 diabetes. Diabetes Care 31 5 (2008) 940-944
14. Mondo C.K., Zhang Y., de Macedo Possamai V., Miao Y., Schyvens C.G., McKenzie K.U., Hu L., Guo Z., and Whitworth J.A. N-acetylcysteine antagonizes the development but does not reverse ACTH-induced hypertension in the rat. Clinical and Experimental Hypertension 28 2 (2006) 73-84
15. Pechanova O., Zicha J., Kojsova S., Dobesova Z., Jendekova L., and Kunes J. Effect of chronic N-acetylcysteine treatment on the development of spontaneous hypertension. Clinical Science (London) 110 2 (2006) 235-242
16. Rauchova H., Pechanova O., Kunes J., Vokurkova M., Dobesova Z., and Zicha J. Chronic N-acetylcysteine administration prevents development of hypertension in N(omega)-nitro-l-arginine methyl ester-treated rats: the role of reactive oxygen species. Hypertension Research 28 5 (2005) 475-482
17. Schuijt M.P., Tom B., de Vries R., Saxena P.R., Sluiter W., van Kats J.P., and Danser A.H. Superoxide does not mediate the acute vasoconstrictor effects of angiotensin II: a study in human and porcine arteries. Journal of Hypertension 21 12 (2003) 2335-2344
18. Tammaro P., Smith A.L., Hutchings S.R., and Smirnov S.V. Pharmacological evidence for a key role of voltage-gated K+ channels in the function of rat aortic smooth muscle cells. British Journal of Pharmacology 143 2 (2004) 303-317
19. Touyz R.M. Activated oxygen metabolites: do they really play a role in angiotensin II-regulated vascular tone?. Journal of Hypertension 21 12 (2003) 2235-2238
20. Weir E.K., Wyatt C.N., Reeve H.L., Huang J., Archer S.L., and Peers C. Diphenyleneiodonium inhibits both potassium and calcium currents in isolated pulmonary artery smooth muscle cells. Journal of Applied Physiology 76 6 (1994) 2611-2615
21. 2- in DOCA-salt rats. Hypertension 43 2 (2004) 329-334
22. Xu H., Bian X., Watts S.W., and Hlavacova A. Activation of vascular BK channel by tempol in DOCA-salt hypertensive rats. Hypertension 46 5 (2005) 1154-1162
23. Xu H., Jackson W.F., Fink G.D., and Galligan J.J. Activation of potassium channels by tempol in arterial smooth muscle cells from normotensive and deoxycorticosterone acetate-salt hypertensive rats. Hypertension 48 6 (2006) 1080-1087
24. Zicha J., Dobesova Z., and Kunes J. Antihypertensive mechanisms of chronic captopril or N-acetylcysteine treatment in L-NAME hypertensive rats. Hypertension Research 29 12 (2006) 1021-1027